IL200690A - Mutant viruses and methods for their creation and use - Google Patents

Mutant viruses and methods for their creation and use

Info

Publication number
IL200690A
IL200690A IL200690A IL20069009A IL200690A IL 200690 A IL200690 A IL 200690A IL 200690 A IL200690 A IL 200690A IL 20069009 A IL20069009 A IL 20069009A IL 200690 A IL200690 A IL 200690A
Authority
IL
Israel
Prior art keywords
making
methods
mutant reoviruses
reoviruses
mutant
Prior art date
Application number
IL200690A
Other languages
English (en)
Hebrew (he)
Other versions
IL200690A0 (en
Original Assignee
Oncolytics Biotech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oncolytics Biotech Inc filed Critical Oncolytics Biotech Inc
Publication of IL200690A0 publication Critical patent/IL200690A0/en
Publication of IL200690A publication Critical patent/IL200690A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K2035/11—Medicinal preparations comprising living procariotic cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/13—Tumour cells, irrespective of tissue of origin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011—Details
    • C12N2720/12011—Reoviridae
    • C12N2720/12021—Viruses as such, e.g. new isolates, mutants or their genomic sequences
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011—Details
    • C12N2720/12011—Reoviridae
    • C12N2720/12022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Virology (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL200690A 2007-05-21 2009-09-02 Mutant viruses and methods for their creation and use IL200690A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US93925507P 2007-05-21 2007-05-21
PCT/CA2008/000964 WO2008141448A1 (en) 2007-05-21 2008-05-21 Mutant reoviruses and methods of making and using

Publications (2)

Publication Number Publication Date
IL200690A0 IL200690A0 (en) 2011-08-01
IL200690A true IL200690A (en) 2014-02-27

Family

ID=40031362

Family Applications (1)

Application Number Title Priority Date Filing Date
IL200690A IL200690A (en) 2007-05-21 2009-09-02 Mutant viruses and methods for their creation and use

Country Status (14)

Country Link
US (1) US20080292594A1 (OSRAM)
EP (1) EP2150613B1 (OSRAM)
JP (1) JP2010527593A (OSRAM)
CN (2) CN101679953A (OSRAM)
AR (1) AR066649A1 (OSRAM)
AU (1) AU2008253505B2 (OSRAM)
CA (1) CA2680661C (OSRAM)
DK (1) DK2150613T3 (OSRAM)
ES (1) ES2611455T3 (OSRAM)
IL (1) IL200690A (OSRAM)
MX (1) MX2009012420A (OSRAM)
TW (1) TW200909581A (OSRAM)
WO (1) WO2008141448A1 (OSRAM)
ZA (1) ZA200907017B (OSRAM)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0720624D0 (en) * 2007-10-20 2007-11-28 Academisch Ziekenhuis Leiden Viral Modification
MX2010003556A (es) * 2007-10-22 2010-04-21 Oncolytics Biotech Inc Regimen de tratamiento para trastornos proliferantes.
CA2723580A1 (en) * 2008-05-27 2009-12-03 Oncolytics Biotech Inc. Modulating interstitial pressure and oncolytic viral delivery and distribution
EP2296679A4 (en) * 2008-05-27 2012-03-21 Oncolytics Biotech Inc SUPPRESSION OF PRODUCTION OF PRO-INFLAMMATORY CYTOKINES DURING ONCOLYTIC REOVIRUS THERAPY
WO2012075376A2 (en) 2010-12-02 2012-06-07 Oncolytics Biotech Inc. Lyophilized viral formulations
EA201390810A1 (ru) 2010-12-02 2013-09-30 Онколитикс Байотек Инк. Жидкие вирусные составы
US20160271193A1 (en) 2013-11-15 2016-09-22 Oncolytics Biotech Inc. Oncolytic viruses and increased cancer treatment regimens
WO2017141942A1 (ja) 2016-02-16 2017-08-24 国立大学法人大阪大学 線維化を治療するための医薬組成物
KR20210098202A (ko) * 2020-01-31 2021-08-10 바이로큐어 주식회사 레오바이러스를 유효성분으로 포함하는 대장염의 예방 또는 치료용 조성물
CN116917468A (zh) * 2020-12-22 2023-10-20 百洛克株式会社 新型修饰的呼肠孤病毒及其用途

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4554101A (en) * 1981-01-09 1985-11-19 New York Blood Center, Inc. Identification and preparation of epitopes on antigens and allergens on the basis of hydrophilicity
US5023252A (en) * 1985-12-04 1991-06-11 Conrex Pharmaceutical Corporation Transdermal and trans-membrane delivery of drugs
US6136307A (en) * 1997-08-13 2000-10-24 Oncolytics Biotech Inc. Reovirus for the treatment of cellular proliferative disorders
US6110461A (en) * 1997-08-13 2000-08-29 Oncolytics Biotech Inc. Reovirus for the treatment of neoplasia
US6565831B1 (en) * 1999-02-24 2003-05-20 Oncolytics Biotech Inc. Methods for preventing reovirus recognition for the treatment of cellular proliferative disorders
DK1098961T3 (da) * 1998-06-12 2008-05-26 Andrej Y Dr Egorov Gensplejsede svækkede vira, der inducerer interferon
TWI289158B (en) * 2000-08-10 2007-11-01 Oncolytics Biotech Inc Method of producing infectious reovirus
MXPA03004029A (es) * 2000-11-09 2004-02-12 Oncolytics Biotech Inc Metodos para tratamiento de trastornos proliferativos celulares.
MXPA03007535A (es) * 2001-03-16 2003-12-11 Oncolytics Biotech Inc Metodo para extraer virus de cultivo celular.
US7163678B2 (en) * 2002-11-07 2007-01-16 Oncolytics Biotech Inc. Reovirus for the treatment of ral-mediated cellular proliferative disorders
WO2005111200A1 (en) * 2004-05-17 2005-11-24 Universite De Montreal Novel strains of reoviruses and methods of uses thereof
EP1917351A4 (en) * 2005-08-01 2009-12-16 Univ Technologies Int ATTENUATED REOVIRUS

Also Published As

Publication number Publication date
CN101679953A (zh) 2010-03-24
TW200909581A (en) 2009-03-01
CA2680661A1 (en) 2008-11-27
IL200690A0 (en) 2011-08-01
EP2150613A4 (en) 2011-01-19
US20080292594A1 (en) 2008-11-27
MX2009012420A (es) 2009-12-09
CA2680661C (en) 2018-05-29
ES2611455T3 (es) 2017-05-09
HK1136006A1 (en) 2010-06-18
WO2008141448A1 (en) 2008-11-27
ZA200907017B (en) 2010-12-29
AR066649A1 (es) 2009-09-02
AU2008253505B2 (en) 2014-09-04
EP2150613A1 (en) 2010-02-10
CN104195115A (zh) 2014-12-10
EP2150613B1 (en) 2016-10-19
DK2150613T3 (en) 2017-01-30
AU2008253505A1 (en) 2008-11-27
JP2010527593A (ja) 2010-08-19

Similar Documents

Publication Publication Date Title
EG27167A (en) Microemulsifiers and methods of making and using same
IL262205A (en) Protein formulations and methods for their preparation
IL205977A0 (en) 5-anilinoimidazopyridines and methods of use
IL200690A (en) Mutant viruses and methods for their creation and use
AU2009234373A8 (en) Coferons and methods of making and using them
EP2262450A4 (en) IMPLANTS AND METHODS OF USE
IL222947A0 (en) Luminaire and methods of use
ZA200905626B (en) Adjuvants and methods of using them
ZA201001051B (en) Benzylbenzene derivatives and methods of use
ZA200710173B (en) Tygecycline and methods of preparing 9-nitrominocycline
IL196956A0 (en) Aza-benzofuranyl compounds and methods of use
GB0719577D0 (en) Microimplant devices and methods of making and use thereof
IL197060A0 (en) Aza-benzothiophenyl compounds and methods of use
ZA201008483B (en) Diazacarbazoles and methods of use
IL206125A0 (en) Azaindolizines and methods of use
HRP20160902T1 (hr) Pripravci i postupci uporabe forbolskih estera
GB0700372D0 (en) Device and methods of using device
IL209548A0 (en) Diazacarbazoles and methods of use
TWI370107B (en) Novel methods for making and using halosilylgermanes
GB201002469D0 (en) Parthenote-derived stem cells and methods of making and using them
EP2170988A4 (en) POLYSTYRENE COMPOSITIONS AND METHODS FOR PREPARING AND USING SAME
ZA201004894B (en) Nuctraceutical composition and methods of use
ZA200900896B (en) Aza-benzofuranyl compounds and methods of use
IL186277A0 (en) Dnt-maleate and methods of preparation thereof
ZA200901009B (en) Aza-benzothiophenyl compounds and methods of use

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed